Tropisetron
Back to searchMolecule Structure
Scientific Name
Tropisetron
Description of the Drug
Tropisetron is a 5HT-3 receptor antagonist used as an antiemetic in the treatment of chemotherapy-induced nausea and vomiting.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11699
http://www.drugbank.ca/drugs/DB11699
Brand Name(s)
Navoban
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Serotonin 3 (5-HT3) receptor | PROTEIN COMPLEX GROUP | ANTAGONIST | CHEMBL2094132 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL18297 |
| DrugBank | DB11699 |
| PubChem: Thomson Pharma | 15222410 |
| LINCS | LSM-46040 |
| Nikkaji | J22.211I |
| PDBe | TKT |
| BindingDB | 50108392 |
| EPA CompTox Dashboard | DTXSID2044137 |
| DrugCentral | 2775 |
| Guide to Pharmacology | 260 |
| rxnorm | TROPISETRON |
| PubChem: Drugs of the Future | 12013648 |
| KEGG Ligand | C13666 |
| ChEBI | 32269 |
| ZINC | ZINC000100019233 |
